le) cy c e H y typ e gor NC n am l (M ate too l a2 c Too Sub PSM ar e PSM Cold Chain and Logistics Management: An Essential fact sheet Financing; Warehousing MNCH Part of Safe and Effective Vaccination Programs Financial Resources required to Achieve Financing; Planning, Universal Access to HIV, fact sheet HIV/AIDS; MNCH budgeting & forecasting Prevention, Treatment, Care and Support Financial Resources required to Achieve Universal Access to HIV, Financing; Planning, fact sheet HIV/AIDS; MNCH Prevention, Treatment, budgeting & forecasting Care and Support - Methodology Malaria Subaccounts: A Financing; M&E; Planning, National Resource fact sheet Malaria; MNCH budgeting & forecasting Tracking Tool Financing; Inspection & Medicines: corruption and fact sheet QA; Manufacturing; MNCH pharmaceuticals Procurement Multi-country regional pooled procurement of medicines - Identifying key principles for enabling regional pooled HIV/AIDS; Malaria; MNCH; fact sheet Financing; Procurement procurement and a RH; TB framework for inter- regional collaboration in the African, Caribbean and Pacific Island Countries Novel and Alternative Approaches to Estimate Financing; Planning, fact sheet HIV/AIDS; MNCH Global Resource Needs to budgeting & forecasting HIV and AIDS Advocacy; Delivery & clearance; Financing; Information systems; Inspection & QA; M&E; Pharmaceutical Manufacturing; Needs & fact sheet MNCH Management Framework demand generation; Planning, budgeting & forecasting; Procurement; Service provision & RU; Warehousing State of the World's Advocacy; Financing; Vaccines and fact sheet Inspection & QA; Service MNCH immunization provision & RU Sustainable Elimination of Advocacy; Financing; M&E; fact sheet MNCH Iodine Deficiency Service provision & RU Cost-Effectiveness and Financing; Planning, guide HIV/AIDS; MNCH HIV/AIDS budgeting & forecasting Drugs and Money - Prices, Financing; Planning, HIV/AIDS; Malaria; MNCH; Affordability and Cost guide budgeting & forecasting; RH; TB Containment Procurement European strategy for Advocacy; Distribution; child and adolescent guide MNCH M&E health and development European strategy for child and adolescent Advocacy; Distribution; guide MNCH health and development - M&E Action tool European strategy for child and adolescent Advocacy; Distribution; guide MNCH health and development - M&E Assessment tool European strategy for child and adolescent Advocacy; Distribution; guide MNCH health and development - M&E Information tool Financial Sustainability guide Financing; M&E MNCH Diagnostic Tool (FSDT) HAPSAT: Using HAPSAT for Financing; Needs & HIV Program Sustainability demand generation; guide HIV/AIDS; MNCH Analysis: An Introductory Planning, budgeting & Guide forecasting; Delivery & clearance; Distribution; Financing; Information systems; HIV/AIDS Commodity Inspection & QA; M&E; Security: A Framework for guide HIV/AIDS; MNCH Needs & demand Strategic Planning generation; Planning, budgeting & forecasting; Procurement; Warehousing Financing; Information systems; Inspection & QA; Needs & demand Immunization Essentials - generation; Planning, guide MNCH A practical field guide budgeting & forecasting; Procurement; Service delivery & RU; Warehousing Financing; Information Laboratory Logistics systems; Inspection & QA; Handbook: A Guide to Needs & demand HIV/AIDS; Malaria; MNCH; Designing and Managing guide generation; planning, TB Laboratory Logistics budgeting & forecasting; Systems Procurement; Warehousing Delivery & clearance; Procurement Strategies Distribution; Financing; for Health Commodities: Inspection & QA; Needs & An Examination of guide demand generation; MNCH Options and Mechanisms Procurement; Service within the Commodity provision & RU; Security Context Warehousing Rapid Pharmaceutical Financing; Inspection & Management Assessment: HIV/AIDS; Malaria; MNCH; guide QA; M&E; Service provision An Indicator-Based RH; TB & RU Approach Strategic Pathway to Reproductive Health Commodity Security guide (all) MNCH (SPARHCS) Tool - A Tool for Assessment, Planning, and Implementation Strategic Pathway to Reproductive Health Commodity Security (SPARHCS) Tool - A Tool guide (all) MNCH for Assessment, Planning, and Implementation - Part 3: Diagnostic guide Advocacy; Delivery & clearance; Financing; Strategies for an Information systems; Expanded and Inspection & QA; Needs & Comprehensive Response guide demand generation; HIV/AIDS (ECR) to a National Planning, budgeting & HIV/AIDS Epidemic forecasting; Procurement; Services provision & RU; Warehousing The SPARHCS Process Guide: A Planning Resource to Improve guide (all) MNCH Reproductive Health Commodity Security Guidelines for preparing a Financial Sustainability guidelines Financing; M&E MNCH Plan (FSP) for a national immunization program Immunization, Vaccines and Biologicals - WHO- UNICEF Guidelines for Financing; Planning, guidelines MNCH developing a budgeting & forecasting comprehensive multi-year plan (cYMP) Medicine pricing matters: Advocacy; Financing; improved availability of guidelines Planning, budgeting & MNCH essential medicines forecasting needed Medicine pricing matters: Advocacy; Financing; improving the availability guidelines Planning, budgeting & MNCH and affordability of forecasting essential medicines Distribution; Financing; Information systems; Checklist to assist with Inspection & QA; M&E; defining needs for Needs & demand technical assistance for list Malaria; MNCH generation; Planning, policy change and budgeting & forecasting; implementation of ACT Service provision & RU; Warehousing CES: Cost-estimate strategy for Reproductive Financing; Planning, Health Commodity manual MNCH; RH budgeting & forecasting Management - User's guide Financing; Inspection & GAVI Alliance Handbook manual QA; M&E; Service provision MNCH & RU Immunization, Vaccines and Biologicals - Financing; Planning, Immunization Costing and manual MNCH budgeting & forecasting Financing: A Tool and User Guide for cMYP Distribution; Financing; Indicators for Monitoring Inspection & QA; M&E; HIV/AIDS; Malaria; MNCH; manual National Drug Policies Procurement; Service RH; TB provision & RU Distribution; Financing; Medicines Transparency Inspection & QA; Alliance - Data disclosure manual Manufacturing; M&E; MNCH survey Procurement; Service provision & RU Distribution; Financing; Medicines Transparency Inspection & QA; Alliance - Pharmaceutical manual Manufacturing; M&E; MNCH sector scan Procurement; Service provision & RU Financing; Planning, HIV/AIDS; Malaria; MNCH; ABC/VEN software software budgeting & forecasting; RH; TB Procurement Financing; Needs & demand generation; HAPSAT for Excel 2003 software HIV/AIDS; MNCH Planning, budgeting & forecasting; Financing; Needs & demand generation; HAPSAT for Excel 2007 software HIV/AIDS; MNCH Planning, budgeting & forecasting; Financing; Needs & HAPSAT: HIV/AIDS demand generation; Program Sustainability software HIV/AIDS; MNCH Planning, budgeting & Analysis Tool forecasting; CES: Cost-estimate strategy for Reproductive Financing; Planning, spreadsheet MNCH; RH Health Commodity budgeting & forecasting Management Immunization, Vaccines and Biologicals - WHO Financing; Planning, spreadsheet MNCH cYMP Costing and budgeting & forecasting Financing Tool Cost Analysis in Primary Health Care: A Training Financing; Planning, HIV/AIDS; Malaria; MNCH; training course material Manual for program budgeting & forecasting RH; TB Managers Immunization Financing e- Financing; Planning, training course material MNCH Learning Module budgeting & forecasting Advanced Immunization Management e-Learning Financing; Planning, website MNCH site budgeting & forecasting Advocacy; Distribution; Financing; Inspection & Essentialdrugs.org website QA; Planning, budgeting & MNCH forecasting; Procurement; Service provision & RU Advocacy; Financing; Strengthening Information systems pharmaceutical systems website MNCH Inspection & QA; M&E; (SPS) Service provision & RU ies ty te di dit pda n y mo io gor mo u sat com ast ate om ani of l c of c c Sub Or g cifi te e Spe Typ Da Vaccines (all) USAID & JSI 2008 Laboratory; Medicines; (all) UNAIDS 2007 Supplements Laboratory; Medicines; (all) UNAIDS 2003 Supplements Laboratory; Medicines; RH (all) Health Systems 20/20 2006 products; Supplements Medicines (all) WHO 2010 Laboratory; Medicines; RH products; Supplements; (all) WHO 2007 Vaccines Laboratory; Medicines; (all) UNAIDS 2007 Supplements Laboratory; Medicines; RH products; Supplements; (all) MSH 2008 Vaccines WHO & UNICEF & World Vaccines (all) 2002 Bank n.a. Iodine UNICEF 2008 Laboratory; Medicines; (all) UNAIDS 1998 Supplements Medicines (all) WHO 2003 Medicines; Supplements; (all) WHO 2005 Vaccines Medicines; Supplements; (all) WHO 2006 Vaccines Medicines; Supplements; (all) WHO 2005 Vaccines Medicines; Supplements; (all) WHO 2006 Vaccines Vaccines (all) WHO & GAVI 2009 Laboratory; Medicines; RH (all) Health Systems 20/20 2010 products; Supplements Laboratory; Medicines; RH (all) USAID | DELIVER Project 2004 products; Supplements Vaccines (all) USAID 2009 Laboratory (all) USAID | DELIVER Project 2010 Laboratory; Medicines; RH (all) USAID | DELIVER Project 2006 products; Supplements Laboratory; Medicines; RH (all) MSH 1995 products; Supplements Medicines; RH products All RH INFO Project 2004 Medicines; RH products All RH INFO Project 2004 Medicines ARV Family Health International 2001 Medicines; RH products All RH INFO Project 2008 Vaccines (all) GAVI 2003 Vaccines (all) WHO 2010 Medicines (all) WHO & HAI 2008 Medicines (all) WHO & HAI 2009 Medicines Anti-malarials MSH 2004 Medicines; RH products (all) MSH 2000 Vaccines (all) GAVI 2008 Vaccines (all) WHO 2010 Medicines (all) WHO 2009 Medicines Transparency Medicines (all) 2010 Alliance (MeTA) Medicines Transparency Medicines (all) 2009 Alliance (MeTA) Medicines; RH products; (all) MSH sd Supplements Laboratory; Medicines; RH (all) Health Systems 20/20 2010 products; Supplements Laboratory; Medicines; RH (all) Health Systems 20/20 2010 products; Supplements Laboratory; Medicines; RH (all) Health Systems 20/20 2010 products; Supplements Medicines; RH products (all) MSH 2000 Vaccines (all) WHO 2005 Laboratory; Medicines; RH (all) WHO 1994 products; Supplements Vaccines (all) PATH - AIM 2009 Vaccines (all) PATH - AIM 2009 Laboratory; Medicines; RH products; Supplements; (all) SATELLIFE 1988 Vaccines Medicines (all) MSH updated regularly te pda use ges n u sio to gua ast Ver en of l L an Wh te Da An effective logistics system and a well-maintained July 2008 - Issue 8 cold chain are essential for safe and effective E immunization service delivery. When estimating the resources needed to tackle HIV/AIDS in the country. The main 2009 report "What countries need - Investments needed for 2010 targets" is an update of the 2007 report which has eleven none methodological annexes. Annex IV describes the E Interventions/Services Included in the Estimates of Resources Needed for HIV and AIDS Annex VIII presents the methodology and assumptions of an analysis of the incremental program costs. When needing more background on the method used for estimating country program costs for HIV/AIDS. UNAIDS used a ‘unit service’ costing model to estimate annual costs for each country program for 2009 through 2015. Total financial requirements include none E costs associated with recommended interventions for HIV prevention, treatment, care, support for children orphaned or made vulnerable by AIDS, as well as certain global costs, such as advocacy, technical assistance and coordination. When producing an expenditure review on a none E particular health priority area such as malaria. This fact sheet gives a brief overview of the key facts regarding corruption in the pharmaceutical supply chain. It focuses on unethical practices in the none E medicines supply chain, factors contributing to pharmaceutical corruption, the impact of corruption, and the response of the WHO This report summarizes the findings of a meeting that provided a forum for sharing experiences from the ongoing regional and global pooled procurement programs and also to explore priority areas for inter- regional collaboration. The main elements identified none E for enabling pooled procurement were: shared political will; pooled procurement models; organization; pricing; patents, financing, sharing of information and experience, capacity building and harmonization. A review of existing approaches identified only one existing comprehensive approach, UNAIDS resource needs model (RNM). This paper proposes two new approaches forecast resource requirements. The first technique, data envelopment analysis (DEA), has none minimal data requirements. It could be used to E determine which countries are most efficient in addressing HIV/AIDS and to examine gaps. The second technique is a combination of the World Bank’s ABC Model (designed for modeling prevention), the GOALS model (which examines treatment and care), and the costing model used in water supply and sanitation (for The SPS Program builds on lessons learned in the Rational Pharmaceutical Management Plus Program and is based on a conceptual framework that combines the U.S. Government’s new foreign none E assistance framework with the pharmaceutical management cycle’s key components of policy, law, and regulation; selection; procurement; distribution; use; management support. When looking got information on how to improve access to underused vaccines, accelerate the discovery none and introduction of priority new vaccines, catalyze E new sustainable financing and raise both political commitment and public demand for immunization. This report has three purposes. First, it reviews the global and national efforts to eliminate IDD during the past two decades. And it shows how governments, the salt industry and communities, with UNICEF support, have made great progress in eliminating iodine none deficiency through universal salt iodization. Second, it E, F, S captures the lessons learned and best practices in the elimination of IDD in various countries. Third, it proposes an agenda against IDD as a vital step towards preventing adverse effects on international development and human potential. Cost-effectiveness analysis is a tool which enables program managers and planners dealing with none E HIV/AIDS to make informed decisions about resource allocation. The document provides policy makers and regulators with a compact and practical review of the various 7th edition approaches that have been developed and tested to E date in an effort to contain the overall costs of pharmaceutical services and drug treatment. This strategy addresses that children are the investment in tomorrow’s society. Their health and the way in which they are nurtured through none E, R adolescence into adulthood will affect the prosperity and stability of countries in the European Region over the coming decades. The tool provides guidance to national and local health ministries and authorities, as well as to governments and international and national NGOs, in reviewing or developing their strategies and work none plans. The tool includes eight tables with actions that E, R have been officially recommended by WHO and other international agencies/entities. The tables address the seven priority areas identified by the Strategy (including maternal and newborn health). The Assessment Tool will clarify whether the necessary measures are in place to ensure achievement of better none E, R health for children and adolescents and identify any areas that require further consideration. This tool is designed for two purposes, which complement one another in the task of moving none towards rational and evidence-based policy, service E, R delivery, and monitoring in Child and Adolescent Health. When preparing financial sustainability plans at the November 2003, revised end of the second year - in case funds from GAVI are E, F version received. The Introductory Guide to the HAPSAT is a tour through the HAPSAT’s capabilities. The guide provides a basic understanding of how to navigate through the none E software, where and how to input data, how to create policy scenarios, and how to obtain results in tables and graphs. This paper presents a framework for strategic planning that brings together a series of functions, programs, none E and activities necessary for the improvement of HIV/AIDS commodity security. The guide provides managers and other decision- makers with scientifically based principles, policies, and standards; technical specifications for vaccines none E, F, S and equipment; and operational considerations that they must weigh to devise the best solutions for their circumstances. This document describes the function and organization of laboratory services and the none commodities needed for laboratory services, and it E discusses supply chain considerations for management of laboratory commodities. This paper describes the key elements of a procurement management system for health commodities—from product selection through the bid management process to the receipt of goods—and the none type of human and organizational capacities needed E to carry out these functions. The analysis also examines the range of available purchasing and financing strategies and options to support and strengthen health commodity supply chains. When conducting an indicator-based assessment of a none E, R, S pharmaceutical system. To help countries develop and implement strategies to none secure essential supplies for family planning and E, F, S reproductive health programs To support stakeholders in conducting a joint none diagnosis of a country’s reproductive health E, F, S commodity security status When designing an expanded and comprehensive HIV/AIDS program. The Handbook strives to provide practical tools, strategies and ideas for designing and implementing expanded and comprehensive HIV/AIDS programs. By building on the lessons learned from none existing programs, it aims to help users design more E comprehensive programs, identify strengths and areas for improvement, and determine opportunities for expansion. The Handbook is divided into eight modules, each with essential information for implementing ECR. Module 6 is about costing of the ERC programs and Module 7 deals with supply chain To provide real world examples and options on how to use the program planning cycle to guide the SPARHCS none process – a set of activities from awareness raising and E, F, S diagnosis, to monitoring the effectiveness of a funded and implemented strategic plan When countries receiving funding from the Vaccine Fund and their development partners prepare the none E, F, P, R Financial Sustainability Plans (that all countries are required to submit at the mid-point in funding). The cMYP guideline is a global document that gives a flexible strategy for planning, and is designed to fit none E, F, R within national planning processes and health sector planning. The lead article in this edition of the HAI and WHO medicines prices survey quarterly bulletin focuses on the need to improve the availability of essential No. 5 E medicines. Since 2003, medicines prices surveys have been carried out in a number of countries using a survey tool designed by WHO and HAI. At a time when over 50 medicines pricing surveys had been completed around the world using the HAI/WHO methodology, the lead article to this edition of the No. 2 medicines pricing survey bulletin considers the need E for guidelines to assist in the creation of policy changes that will help to reduce the price of essential medicines To assist technical support partners to work with countries to assess progress in implementation of activities supporting ACT implementation and in none E, F identifying the areas where technical support is needed and, to provide a checklist for the planning process to identify areas where activities are needed. The CES User’s Guide first provides potential users with basic information about the methodology so that they can determine if the CES is an appropriate tool for them to use. CES consists of two major none components: 1. the CES spreadsheets model the costs E, F, S of commodities for the local situation being reviewed, and 2., step-by-step instructions on how to plan and implement a CES survey of RH commodity management. This Handbook is intended to assist countries and their partners in navigating the proposal process when seeking GAVI Alliance support. It also explains in none E, F, R summary form GAVI’s monitoring requirements and guides its users through the various forms used in the GAVI Alliance proposal and monitoring process. This comprehensive User Guide provides an overview of important concepts, methodologies and definitions. It also provides step-by-step instruction on how to use none E, R the cMYP Costing and Financing Tool, guidance on sources of information, and results analysis, as well as interpretation of findings. The manual includes approximately 120 indicators 2nd edition covering structure, process and outcomes of various E, F national medicines policy (NMP) components. When assessing and describing the current disclosure status of information in the core areas of: medicines registration and quality assurance; the availability of version 31 July 2009 E medicines; the price of medicines; and the policies and practices concerning the promotion of medicines. When collecting baseline information on the way medicines for primary care are regulated, supplied and used and to highlight key information gaps. The information covers eight areas: (1) Country profile, (2) none E Medicines policy and regulatory framework, (3) Medicines market, (4) Medicines financing, (5) Medicines trade, (6) Medicines supply system, (7) Medicines access, (8) Medicines use. This is a tool that allows a planner or manager to analyze expenditures for pharmaceuticals and medical supplies to determine priorities in procurement and inventory management and to assist in making decisions on which items to include on a formulary. none ABC analysis is a powerful tool by which items are E, F, S compared according to their total cost, allowing the planner to prioritize the management of class A items (10-20% of items that account for 70-80% of funds spent) in selection and procurement decisions. VEN analysis is a system of setting priorities, in which drugs are classified according to their health impact: vital, The model synthesizes detailed epidemiological, demographic, and service delivery data to generate a none E country-specific HIV/AIDS policy model that can be used to simulate multiple alternative policy scenarios. The model synthesizes detailed epidemiological, demographic, and service delivery data to generate a none E country-specific HIV/AIDS policy model that can be used to simulate multiple alternative policy scenarios. When forecasting and analyzing the sustainability of HIV/AIDS programs during periods of service delivery scale-up and/or when facing limited or unknown future resource levels. The HAPSAT tool enables policy none E and implementation officials to estimate the amount of financial and human resources necessary for the successful delivery of services within a national HIV/AIDS program. The tool offers spreadsheet models to estimate program commodity costs—following identification of essential reproductive health commodities—and sample survey instruments to gather information on none E, F, S current practices in reproductive health commodity management. The cost estimation is based on standard treatment guidelines for the selected reproductive health conditions and services. To help undertake the costing and financing of a comprehensive multi-year plan (cMYP), the cMYP Costing and Financing Tool can be used to estimate the past costs and financing of immunization, and to Version 2.4 E, F make projections of future costs, future resources requirements, future financing needs to achieve program objectives, and analyze the corresponding financing gaps. When public health program mangers require guidance on how to use cost analysis and cost- (all) E effectiveness analysis to achieve better understanding and management of resource flows. This e-learning module is designed to teach senior immunization managers the financial planning and E, F, R and Bahasa none budgeting skills that will help their programs reach Indonesian their goals and remain successful. The AIM e-Learning tool is designed to provide comprehensive information to support immunization E, F, R and Bahasa none program managers at all stages of country-level Indonesian decision-making. This is the English language discussion group of essentialdrugs.org. Its objective is to support the concept of essential drugs by improving and speeding up communications among all health professionals none working in the field of essential drugs. Discussions E, F, R, S focus on topics such as rational use of drugs, drug policy, economics and financing, supply and marketing, legislation and regulation, quality assurance and safety, and training. The aim of SPS is to continue and expand existing work and focus good governance in the pharmaceutical sector, pharmaceutical care, none E pharmacovigilance, laboratory services, health financing, and innovative mechanisms to enhance access to medicines. L an gua ges C C C, D, F Ad min istr at ive lev el o f us e pdf - 65 kB pdf - 148 kB pdf - 1,2 MB For m& size none none none Am oun t of t rain ing / TA req uir e d C, R pdf - 224 kB none C, D, F, R mhtml - 99 kB none R pdf - 435 kB none C pdf - 135 kB none C, D, F, R pdf - 298 kB none C, R pdf - 2,9 MB none C, R pdf - 1,2 MB none TA from economists C pdf - 330 kB required or extra training of accountants. C, D, F, R pdf - 1 MB none C pdf - 382 kB none C pdf - 249 kB none C pdf - 245 kB none C pdf - 264 kB none C pdf - 175 kB One week. Health Systems 20/20 can provide technical assistance with implementation of HAPSAT C pdf - 5,44 MB into an M&E or strategic planning process. Contact your country USAID office for further information. C pdf - 1,5 MB none C pdf - 3,7 MB none C, D, F, R pdf - 1,2 MB none C, D, F pdf - 2MB none Data collectors must be C, D, F, R pdf - 490 kB well trained. variable (countries can customize the approach to C, D, R pdf - 702 kB their own needs and resources) variable (countries can customize the approach to C, D, R Word - 368 kB their own needs and resources) C pdf - 921 kB & website none variable (countries can pdf - 809 kB/CD Rom (with customize the approach to C, D, R all material) their own needs and resources) C pdf - 291 kB none No prior experience or C pdf - 637 kB formal training in health economics is necessary C, D, F, R pdf - 4,5 MB none C, D, F, R pdf - 935 kB none C pdf none Full implementation of the CES methodology requires a range of skills and a real commitment of resources. Ideally a CES C, D, F pdf - 2,8 MB implementation team would include members with clinical expertise in reproductive health, pharmaceutical and supply management expertise, operational service C pdf - 508 kB none No prior experience or C pdf - 2,7 MB formal training in health economics is necessary C pdf - 1MB none This tool does not require external technical assistance or financial C Word - 491 kB resources. Data collectors require knowledge of the pharmaceutical sector and supply chain. Technical assistance not needed, but data collection requires a team of three to four individuals who are familiar with the C Word - 2,2 MB health and pharmaceutical sector in the country – this could be an independent academic team. Implementation of the assessment on average requires around 20-30 software application - 2,4 C, D, F, R none MB Health Systems 20/20 can provide technical assistance with implementation of HAPSAT C Excel 2003 - 1,8 MB into an M&E or strategic planning process. Contact your country USAID office for further information. Health Systems 20/20 can provide technical assistance with implementation of HAPSAT C Excel 2007 - 1 MB into an M&E or strategic planning process. Contact your country USAID office for further information. Health Systems 20/20 can provide technical assistance with implementation of HAPSAT C PowerPoint presentation into an M&E or strategic planning process. Contact your country USAID office for further information. Full implementation of the CES methodology requires a range of skills and a real commitment of resources. Ideally a CES C, D, F spreadsheet, diskettes implementation team would include members with clinical expertise in reproductive health, pharmaceutical and supply management expertise, operational service No prior experience or C Excel - 3,4 MB formal training in health economics is necessary C, D, F, R pdf - 4,9 MB none E-learning at person's pace. Facilitator guides are available on how to design pdf - 2,3 MB (Welcome) & C and conduct face-to-face CD-Rom & hard copy sessions and how to introduce this e-learning module. E-learning at person's pace. Facilitator guides are available on how to design C website and conduct face-to-face sessions and how to introduce this e-learning module. C, D, F website & e-mail none C, D, F, R website & pdf - 253 kB none d e uir req uts TA ges utp / nta ing t &o Co s rain va uts Ad of t Inp t oun Am Indeed a snapshot of issues that play in cold chain and logistics management of vaccines, dealing none Free with requirements of cold chain equipment, what countries can do to protect their cold chain, … Additional details regarding the methodology employed by UNAIDS to estimate costs for each scenario are available in the eleven none Free methodological annexes (dealing with estimating HIV/AIDS program costs using the Global Resources Needs mode)l. Brief fact sheet of methodology none Free used for the country estimations of HIV and AIDS resource needs. The National Health Accounts (NHA) framework is an effective way to track resources and none Free produce data on key financial indicators. Brief overview of the unethical practices in the medicines supply none Free chain, the factors that contribute to pharmaceutical corruption and the impact of corruption. Includes discussion of all elements related to pooled procurement and issues relating to none Free challenges/constraints. Describes principles, solutions and recommendations. Both approaches could be used simultaneously and would complement one another. The extension of ABC model provides the detail to ensure that the best none Free indicators are chosen by the global model while the global model ensures that activities are classified and measured in ways that are internationally consistent. Presentation of the procurement none Free and supply chain cycle. Authoritative survey on vaccines and immunization covers immunization challenges including financing, new vaccine introduction none Free and other major issues in service delivery. It also provides useful information on vaccines and vaccine-preventable diseases. Overview of the progress made in iodine deficiency elimination since none Free the 1990 World Summit for Children. Inputs: direct and indirect costs related Simplified standardized step-by- to HIV/AIDS interventions. Output: step explanation of how to conduct Free Assessment of efficiency and estimation a cost-effectiveness analysis of of future resource requirements. HIV/AIDS porgrammes. More of an overview of different none Free approaches of cost containment, rather than guidance on what to do. This document provides an umbrella strategy for the large number of existing, evidence-based initiatives currently being none Free promoted by the Regional Office to support the health and development of children and adolescents. Comprehensive framework to identify roles and responsibilities in none Free developing and implementing a national strategy for children and adolescents. The tool is designed to allow policy- makers and planners to undertake a formative assessment of their none Free current policy situation and analyze their state of readiness with regard to implementation. This use of the this tool will enable information staff and policy makers to review the adequacy of their none Free current information systems, and to make any appropriate recommendations for change. Inputs: questionnaire. Outputs: identification of the strengths of the current financing of immunization Follows the Financial Sustainability programs, highlighting areas for further Free Plan guidelines and can be adapted improvement, and identification of what to country needs. type of capacity building is required to prepare, implement and monitor Financial Sustainability Plans. HAPSAT is a tool that allows strategic information from multiple sources to be synthesized and Inputs: Wide range of primary data leveraged to provide transparent, (Questionnaires for obtaining data are flexible evidence-based decision- available). Output: projection of the costs Free making. The HAPSAT model can be and resource needs for each program harmonized with the SPECTRUM area. policy modeling system to make demographic and epidemiological projections. Explains step by step the essential none Free elements of a HIV/AIDS commodity security framework Very comprehensive guide. Provides information on none Free immunization programs that is practical as well as technically and operationally sound. The unique characteristics of laboratory commodities impact the way in which the supply chain none Free should be designed and managed to ensure the availability of these commodities, and this is explained and described in this document. Examples from several countries are used to highlight current practices, recurring challenges, and none Free the array of choices faced by public sector programs and procurement agencies. The tool can be modified to target specific aspects of a Output: pharmaceutical system pharmaceutical system; provides a Free assessment. rapid means for conducting indicator-based assessments, for baseline or monitoring purposes. Flexible: SPARHCS can be used for contraceptives alone, for contraceptives and condoms for HIV/STI prevention, or for a still Inputs: variable (countries can customize broader set of reproductive health the approach to their own needs and supplies. It can be used at national Free resources); Output: country assessment or subnational levels; in countries regarding RHCS more or less experienced in working on reproductive health commodity security; in countries not yet ready to phase out donor support or in countries planning for Flexible: the guide is designed to Inputs: variable (countries can customize facilitate diagnosis rather than be a the approach to their own needs and checklist or questionnaire. Free resources); Output: country assessment Questions can be rewritten or regarding RHCS deleted according to user needs; new ones can be added. The Handbook offers specific strategies, both operational and technical, for developing an ECR, and it can be adapted to meet the needs of various populations at none Free different levels of the epidemic. Module 7: definition of the types of drugs, health commodities and laboratory equipment required for ECR; discussion of the different stages of the drug and health commodity cycle, including Inputs: variable (countries can customize the approach to their own needs and Comprehensive planning cycle Free resources); Output: country assessment guidance for RHCS regarding RHCS The document describes the purpose, suggested content and format, and process for none Free preparation of the Financial Sustainability Plan. Annexes provide additional background materials and technical resources. Presents a series of steps to none Free develop a cMYP. Includes advocacy for availability of none Free essential medicines and campaign "Stop stock-outs". Inputs: all price surveys conducted by WHO & HAI. Output: guidelines on Start of a process to develop options for policies affecting medicine Free guidelines on policies that affect prices, outlining what is known about medicine prices. their application and impact in differing settings. The questionnaire has 14 sections—policy change, financing and resource mobilization, planning and coordination, revision of regulations, essential medicines none Free list and standard treatment guidelines (rational use), communication, phasing out old drugs, phasing in new drugs, quantification and forecasting, procurement, distribution, inventory management, quality Depending upon the user’s none Free objectives, it may not be necessary to read all chapters. Users are directed to web-based none Free resources where relevant. Materials will be continually improved and updated on none Free www.who.int/immunization_financi ng/tools Comprehensive set of simple, objective and reliable indicators which can be adapted to fit national contexts. The manual Inputs: background indicators (31); focuses on relatively low-cost and structural indicators (50); process Free non-complex methods that can be indicators (38); outcome indicators (10). used with limited specialist input and integrated into routine monitoring systems. This tool enables national stakeholders to prioritize activities and facilitates progressive disclosure over time. It creates a Inputs: data collection. Output: baseline against which changes in disclosure of country's pharmaceutical Free transparency and disclosure can be data. measured. It also facilitates multi- stakeholder engagement since it requires that the stakeholders disclose relevant information they and the institutions they represent hold. This information is then cross The set of baseline tools contains instructions, data collection forms and supporting sources and comments document. This tool Inputs: data collection. Output: country Free allows the user to collate a core set pharmaceutical sector scan. of information about a country’s pharmaceutical sector and points to areas where key information gaps exist. A useful tool to guide users through ABC/VEN analyses - without a spreadsheet. The program comes with a list of over 600 essential drugs, in order to Inputs: consumption data, price data. reduce data entry requirements, Free Output: ABC analysis & VEN analysis. and can process and store any number of data sets. This allows the user to compare, for example, 2006 data with 2007 data, or compare one region to another. HAPSAT produces estimates of the Inputs: Wide range of primary data financial and human resources (Questionnaires for obtaining data are required to sustain and/or scale up available). Output: projection of the costs Free a comprehensive portfolio of and resource needs for each program quality HIV/AIDS services. Various area. parts of the HAPSAT analysis can be customized to serve country needs. HAPSAT produces estimates of the Inputs: Wide range of primary data financial and human resources (Questionnaires for obtaining data are required to sustain and/or scale up available). Output: projection of the costs Free a comprehensive portfolio of and resource needs for each program quality HIV/AIDS services. Various area. parts of the HAPSAT analysis can be customized to serve country needs. HAPSAT produces estimates of the Inputs: Wide range of primary data financial and human resources (Questionnaires for obtaining data are required to sustain and/or scale up available). Output: projection of the costs Free a comprehensive portfolio of and resource needs for each program quality HIV/AIDS services. Various area. parts of the HAPSAT analysis can be customized to serve country needs. Serves as a planning, budgeting and Inputs: data of RH pharmaceuticals and management tool for reproductive commodities (sample survey instruments health commodity management. are included in the User's Guide), e.g. The Cost-Estimate Strategy is a target population, treatment regimens, flexible tool. Depending upon the etc. Output: information on commodity Free needs of the user, one or more of management, especially in regard to (1) the costing models may be service and commodity availability, (2) employed, and, if appropriate, the use of reproductive health commodities, survey component undertaken. It and (3) local cost of RH commodities. can be applied to RH programs at national or lower administrative levels, or to an individual health Inputs: three worksheets have to be completed: (1) Data entry worksheet- Includes a sheet with Instructions. calculations of vaccines, injection There's also a document with the supplies, staff, and other recurrent costs, main issues since the latest revision (2) Financing worksheet - future available Free available at secured and non-secured financing, (3) http://www.who.int/immunization_ Co-financing worksheet. Outputs: financing/tools/Tool_Revisions_201 estimation of the cost of the cMYP 0_July10.pdf immunization program. Inputs: reading and exercising. Output: Training exercises are included to understanding of cost effectiveness and Free provide practice in collecting and data. interpreting cost data. Comprehensive e-learning module with tools for costing and budgeting immunization programs. Inputs: time to browse through all the Free Links to Excel, Word and learning module sections. PowerPoint documents explaining more on vaccine prices and financing. The AIM e-Learning site is a response to requests from Inputs: time to browse through all the immunization professionals for Free learning module sections. comprehensive and up-to-date information on new and underutilized vaccines. Discussions focus on topics such as rational use of drugs, drug policy, economics and financing, supply Inputs: online forum and group Free and marketing, legislation and discussions related to drugs. regulation, quality assurance and safety, and training. Based on simple off-line e-mail technology. Wealth of information on MSH none Free work in improving pharmaceutical systems. ges ility s ion nta lab itat va i Ava Lim Ad http://www.immunizationbasics.jsi.com/Newsletter/Archives/snapshot Comprehensive but brief. s_volume8.pdf http://www.unaids.org/en/KnowledgeCentre/Resources/FeatureStories /archive/2007/20070925_Resource_needs_methodology.asp & Annex The main report and annexes IV: explain the methods for estimating http://data.unaids.org/pub/Report/2007/20070925_annex_iv_interven HIV prevention, treatment and tions_en.pdf & Annex VIII: mitigation costs but no guidance http://data.unaids.org/pub/Report/2007/20070925_annex_viii_progra on how to do it. m_costs_en.pdf & main 2009 report: http://data.unaids.org/pub/Report/2007/JC1678_Fin_Res_Req_en.pdf No guidelines on how to estimate http://data.unaids.org/pub/FactSheet/2007/20070925_rn_factsheet_m HIV/AIDS program resource needs. ethodology_final_en.pdf The document explains briefly how NHA subaccounts for malaria can contribute to tracking resource http://www.healthsystems2020.org/content/resource/detail/1887/ needs, without going into details on how to calculate it. Comprehensive but brief. http://www.who.int/mediacentre/factsheets/fs335/en/ Reflection of meeting discussions. http://www.who.int/medicines/publications/PooledProcurement.pdf Overview of the two alternative http://data.unaids.org/pub/Report/2007/20070925_alternative_approa approaches but no guidance. ches_estimate_resource_needs_en.pdf http://www.msh.org/projects/sps/SPS- none Documents/upload/Eng_Pharm_Framework_Letter_rev.pdf none http://www.who.int/vaccines-documents/Docspdf02/www718.pdf English version: http://www.unicef.org/publications/files/Sustainable_Elimination_of_Io dine_Deficiency.pdf; French version: none http://www.unicef.org/french/publications/files/Elimination_durable_d e_la_carence_en_iode.pdf; Spanish version: http://www.unicef.org/spanish/publications/files/Eliminacion_sostenibl e_de_la_carencia_de_yodo.pdf Assumes some knowledge of cost analyses, or requires technical http://data.unaids.org/Publications/IRC-pub03/costtu_en.pdf assistance. none http://apps.who.int/medicinedocs/pdf/s4912e/s4912e.pdf English version: http://www.euro.who.int/__data/assets/pdf_file/0020/79400/E87710. none pdf; Russian version: http://www.euro.who.int/__data/assets/pdf_file/0003/79401/E87710R .pdf English version: http://www.euro.who.int/__data/assets/pdf_file/0011/81848/Action_T none ool.pdf; Russian version: http://www.euro.who.int/__data/assets/pdf_file/0005/82328/Action_T ool_R.pdf The Assessment tool has been designed as a self-completion questionnaire. It may require English version: inputs from a range of key http://www.euro.who.int/__data/assets/pdf_file/0009/82368/Assesme individuals, government nt_tool.pdf; Russian version: department and ministries in order http://www.euro.who.int/__data/assets/pdf_file/0010/82369/Assesme to paint an accurate and reliable nt_Tool_R.pdf picture of the country’s provision for child and adolescent health and development. English version: http://www.euro.who.int/__data/assets/pdf_file/0019/82342/Informat none ion_Tool.pdf; Russian version: http://www.euro.who.int/__data/assets/pdf_file/0020/82361/Informat ion_Tool_R.pdf The FSDT needs to be completed through a series of interviews with English version: all relevant stakeholders both at http://www.who.int/immunization_financing/tools/en/FSDT_En.pdf; national, sub-national and French version: operational level which may have http://www.who.int/immunization_financing/tools/en/FSDT_Fr.pdf some organizational and logistical implications/difficulties. No comprehensive User's Manual http://www.healthsystems2020.org/content/resource/detail/2544/ available yet (coming soon). http://deliver.jsi.com/dlvr_content/resources/allpubs/guidelines/HivaC none SFram.pdf English version: http://pdf.usaid.gov/pdf_docs/PNADG279.pdf OR http://www.transaid.org/images/resources/PNACU960.pdf & French none version: http://pdf.usaid.gov/pdf_docs/PNADG279.pdf & Spanish version: http://pdf.usaid.gov/pdf_docs/PNADJ503.pdf http://deliver.jsi.com/dlvr_content/resources/allpubs/guidelines/LaboL none ogiHand.pdf none http://www.phishare.org/files/4346_PROCUREMENTSTRATEGIES.pdf English version: http://erc.msh.org/toolkit/toolkitfiles/file/rpma3.pdf OR The user must put the study results http://www.msh.org/Documents/HealthManagersToolkit/upload/Rapid in context and write the report. -Pharmaceutical-Management-Assessment.pdf OR http://erc.msh.org/mainpage.cfm?file=4.31.htm&module=toolkit&lang uage=English Technical capacity needed to http://www.maqweb.org/sparhcs conduct the assessment Technical capacity needed to http://www.maqweb.org/sparhcs conduct the assessment Text can be read online as well, but http://www.fhi.org/NR/rdonlyres/elwuussewhozpizshiomzjg6sh33t57kr lacks the facts and figures boxes. clhuil5mudazpqfxrhbsxhwbogfquvsgmtvlfxrel5pkn/ECRenglish1.pdf Technical capacity needed to http://www.maqweb.org/sparhcs conduct the assessment English version: http://www.who.int/immunization_financing/tools/en/FSP_Guidelines_ April%202004_En.pdf; French version: http://www.who.int/immunization_financing/tools/en/FSP_Guidelines_ none April%202004_Fr.pdf; Portuguese version: http://www.who.int/immunization_financing/tools/en/fsp_guidelines_ po.pdf; Russian version: http://www.who.int/immunization_financing/tools/en/FSP_Guidelines_ April%202004_Ru.pdf English version: http://www.who.int/vaccines- documents/Docspdf06/832.pdf & French version: http://whqlibdoc.who.int/hq/2005/WHO_IVB_05.20_fre.pdf & Russian none version: http://www.who.int/immunization_financing/tools/cMYP_Guidelines_R u.pdf none http://www.haiweb.org/medicineprices/15072009/Bulletin5final.pdf http://www.haiweb.org/medicineprices/medprices15052008/Medicine Guidelines not yet included. PricingMatters2.pdf http://www1.msh.org/projects/sps/SPS- none Documents/loader.cfm?csModule=security/getfile&pageid=4640 3 A good knowledge of spreadsheet applications is required to http://pdf.usaid.gov/pdf_docs/PNACM443.pdf successfully use the CES models. English version: http://www.gavialliance.org/resources/Handbook_in_English.pdf & French version: none http://www.gavialliance.org/resources/Handbook_in_French_2008_2.p df & Russian version: http://www.gavialliance.org/resources/Handbook_in_French_2008_2.p df English version: http://www.who.int/vaccines- documents/Docspdf07/848.pdf Russian version: none http://www.who.int/immunization_financing/tools/cMYP_Costing_Tool _Manual_Vs.1.3_Ru.pdf Mainly addressing needs at national level; managers at English version: intermediate and lower levels will http://apps.who.int/medicinedocs/pdf/whozip14e/whozip14e.pdf; probably find the indicators useful French version: but may need more (or more http://apps.who.int/medicinedocs/pdf/whozip15f/whozip15f.pdf detailed) information in relation to their field of intervention. http://www.medicinestransparency.org/resources/meta- Labor-intensive to collect all data. resources/meta-toolkits/ http://www.medicinestransparency.org/resources/meta- Labor-intensive to collect all data. resources/meta-toolkits/ Accurate consumption and price data are needed in order to conduct an ABC analysis. The user http://erc.msh.org/toolkit/Tool.cfm?lang=1&CID=2&TID=218 needs to assign a VEN category to each item to facilitate analysis. No User's Manual available yet (coming soon). Comprehensive http://www.healthsystems2020.org/content/resource/detail/2533/ sustainability analysis but limited to HIV/AIDS programs. No User's Manual available yet (coming soon). Comprehensive http://www.healthsystems2020.org/content/resource/detail/2534/ sustainability analysis but limited to HIV/AIDS programs. No User's Manual available yet (coming soon). Comprehensive http://www.healthsystems2020.org/content/resource/detail/2537/ sustainability analysis but limited to HIV/AIDS programs. A good knowledge of spreadsheet applications is required to successfully use the CES models. The CES models the costs of drugs, medical supplies and equipment http://erc.msh.org/mainpage.cfm?file=4.10.htm&module=toolkit&lang used in the provision of RH services uage=English and the treatment of RH conditions; it does not include other costs (personnel, infrastructure, etc). English version: User Guide may need to be http://www.who.int/immunization_financing/tools/cMYP_Costing_Tool consulted to learn how to enter the _Vs.2.4_En.xls & French version: data and obtain the estimations http://www.who.int/immunization_financing/tools/cMYP_Costing_Tool _Vs.2.4_Fr.xls More up-to-date and practical http://www.who.int/immunization_financing/data/methods/en/caphc_ training manuals for cost analysis creese.pdf maybe available. The online linkages to the e- learning module are divided over English version: http://aim.path.org/en/finance/index.html & French different topics, so several version: http://aim.path.org/fr/finance/index.html & Bahasa Indonesia: browsing sessions and downloads http://aim.path.org/id/finance/index.html & Russian version: are required to get the whole http://aim.path.org/ru/finance/index.html module. Therefore it may be better to order the CD-Rom. none http://aim.path.org/ E-drug is specifically targeted to health workers in developing http://www.essentialdrugs.org/ countries. http://www.msh.org/projects/sps/index2.cfm?CFID=2257151&CFTOKE none N=81109576; http://www.msh.org/projects/sps/SPS- Documents/upload/About-SPS-Flyer.pdf s t ark tac Rem Co n - ImmBasics_Info@jsi.com Report summary available in French, Russian and Spanish. ANNEXES: Methodological Annex - I: Integrating the prevention of violence against women and PEP into the HIV programs: preliminary framework and proposed next steps Methodological Annex - II: Revised Projections of the email@example.com; Number of People in Need of ART firstname.lastname@example.org Methodological Annex - III: Methodology for Care and Treatment Interventions Methodological Annex - IV: Description of Interventions/Services Included in the Estimates of Resources Needed for HIV and AIDS See the main report and methodological annexes for email@example.com more information on the estimation methods. firstname.lastname@example.org - rg WHO Fact sheet N°335, December 2009 email@example.com - firstname.lastname@example.org - Shepard@Brandeis.edu - email@example.com - firstname.lastname@example.org - email@example.com UNAIDS Best Practice Materials - Technical Update firstname.lastname@example.org Contact WHO email@example.com Contact World Health Organization - Regional Office for firstname.lastname@example.org Europe in Denmark or visit www.euro.who.int. Contact World Health Organization - Regional Office for email@example.com Europe in Denmark or visit www.euro.who.int. Contact World Health Organization - Regional Office for firstname.lastname@example.org Europe in Denmark or visit www.euro.who.int. Contact World Health Organization - Regional Office for email@example.com Europe in Denmark or visit www.euro.who.int. - firstname.lastname@example.org General contact email: email@example.com Technical contact email: General website: www.hs2020.com/hapsat Arin_Dutta@abtassoc.com Elaine_Baruwa@abtassoc.c om A hard copy or a CD-Rom can be ordered from the USAID firstname.lastname@example.org | DELIVER PROJECT Contact Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for email@example.com International Development (USAID). A hard copy can be ordered from the USAID | DELIVER firstname.lastname@example.org PROJECT Contact: USAID | DELIVER PROJECT. email@example.com Data collection forms, guidelines, written procedures or protocols, manual/report available. Contact: Center for Pharmaceutical Management at Management Sciences firstname.lastname@example.org for Health. Russian and Spanish versions not available on website. Preferred citation: Hare, L., Hart, C., Scribner, S., at USAID: Contraceptive Shepherd, C., Pandit, T. (ed.), and Bornbusch, A. (ed.). Security Team - c/o Mark 2004. SPARHCS: Strategic Pathway to Reproductive Rilling or Alan Bornbusch, Health Commodity Security. A Tool for Assessment, email@example.com or Planning, and Implementation. Baltimore, MD: firstname.lastname@example.org; at Information and Knowledge for Optimal Health (INFO) UNFPA: c/o Jagdish Project/Center for Communication Programs, Johns Upadhyay, Hopkins Bloomberg School of Public Health. Upadhyay@unfpa.org Preferred citation: Hare, L., Hart, C., Scribner, S., at USAID: Contraceptive Shepherd, C., Pandit, T. (ed.), and Bornbusch, A. (ed.). Security Team - c/o Mark 2004. SPARHCS: Strategic Pathway to Reproductive Rilling or Alan Bornbusch, Health Commodity Security. A Tool for Assessment, email@example.com or Planning, and Implementation. Baltimore, MD: firstname.lastname@example.org; at Information and Knowledge for Optimal Health (INFO) UNFPA: c/o Jagdish Project/Center for Communication Programs, Johns Upadhyay, Hopkins Bloomberg School of Public Health. Upadhyay@unfpa.org Extra module on "Engaging the business sector" has been added in 2004: http://www.fhi.org/NR/rdonlyres/ef3tfxqfhbpo5euo52va email@example.com bu3sbmzhj2ul6qa2n6wsqd65pmrhrivloetdigvjr26kovk2od kg7o2wzi/ECRBusinessModule061504.pdf Preferred citation: Rao, Raja; Olson, Nadia; Bornbusch, at USAID: Contraceptive Alan (ed.); and Pilz, Kevin (ed.). 2008. The SPARHCS Security Team - c/o Mark Process Guide: A Planning Resource to Improve Rilling or Alan Bornbusch, Reproductive Health Commodity Security. firstname.lastname@example.org or Baltimore, MD: Information and Knowledge for Optimal email@example.com; at Health (INFO) Project/Center for Communication UNFPA: c/o Jagdish Programs, Johns Hopkins Bloomberg School of Public Upadhyay, Health. Upadhyay@unfpa.org - firstname.lastname@example.org Contact WHO - Immunization, Vaccines and Biologicals. email@example.com Medicine Pricing Matters, No. 2; Contact Margaret Ewen firstname.lastname@example.org & (HAI) or Alexandre Cameron (WHO) email@example.com Medicine Pricing Matters, No. 2; Contact Margaret Ewen firstname.lastname@example.org & (HAI) or Richard Laing (WHO) email@example.com To learn more or for any questions, please contact SPS firstname.lastname@example.org program at MSH. The Rational Pharmaceutical Management Plus(RPMplus) project, the John Snow, Inc. MotherCare project, and the United States Pharmacopeia (USP) for the US Agency for International Development, and published in 2000. The email@example.com User’s Guide, complete with diskettes containing the spreadsheet and sample survey instrument files, can be obtained by emailing to MSH. For Immunization services support, New vaccine irizzo @ gavialliance.org proposals, Immunization safety support : Dr Ivone Rizzo See www.who.int/immunization_financing/tools for the immunizationfinancing@w spreadsheet tool. ho.int Data collection forms are included in the annexes. firstname.lastname@example.org See MeTA Baseline Assessment Toolkits. The International MeTA Secretariat and the WHO have email@example.com worked with the WHO Collaborating Centre in g Pharmaceutical Policy at Harvard University to develop this tool. See MeTA Baseline Assessment Toolkits. The International MeTA Secretariat and the WHO have firstname.lastname@example.org worked with the WHO Collaborating Centre in g Pharmaceutical Policy at Harvard University to develop this tool. Instructions for use: Download and run the ABCVEN setup.exe file to install the program. There is no user's guide, so you should be sure to read the help file before starting work with the program--there's some important email@example.com information there. Contact person: Julie Frye, Center for Pharmaceutical Management, Management Sciences for Health. General contact email: firstname.lastname@example.org Technical contact email: General website: www.hs2020.com/hapsat Arin_Dutta@abtassoc.com Elaine_Baruwa@abtassoc.c om General contact email: email@example.com Technical contact email: General website: www.hs2020.com/hapsat Arin_Dutta@abtassoc.com Elaine_Baruwa@abtassoc.c om General contact email: firstname.lastname@example.org Technical contact email: General website: www.hs2020.com/hapsat Arin_Dutta@abtassoc.com Elaine_Baruwa@abtassoc.c om The Rational Pharmaceutical Management Plus(RPMplus) project, the John Snow, Inc. MotherCare project, and the United States Pharmacopeia (USP) for the US Agency for International Development, and published in 2000. The email@example.com User’s Guide, complete with diskettes containing the spreadsheet and sample survey instrument files, can be obtained by emailing to MSH. In order to protect the cMYP costing and financing tool from any damages, certain protective measure have been taken and the worksheets have been password protected. If you find that once you open the tool you are unable to enter information into it, it is likely that your computer has an anti-virus protection activated and this immunizationfinancing@w conflicts with the password protection. If this is the case, ho.int you will need to unprotect the tool, save it under a new file name, and re-protect the tool. If you do need to unprotect the tool and its worksheets, the password is: MYPCT. Edited by A. Creese and D. Parker. firstname.lastname@example.org Instructions on use of the e-learning module can be found on http://aim.path.org/en/finance.pdf (English) - (French) - (Bahasa Indonesian), and email@example.com http://aim.path.org/ru/finance.pdf (Russian). Or have a look at AIM e-Learning site: http://aim.path.org/ - firstname.lastname@example.org The site also has links to French, Spanish and Russian language discussion groups - E-MED, E-FARMACOS and E- LEK respectively, to INDIA-DRUG, a national email e-drug- discussion group on the rational use of drugs, and to email@example.com INDICES, to support the creation of an international network of drug information centers. This is the website for the Strengthening Pharmaceutical Systems (SPS) project that supercedes the Rational firstname.lastname@example.org Pharmaceutical Management (RPM) project and Rational Pharmaceutical Management Plus program.